Company News: Sanofi-Aventis and Warner Chilcott

Share this article:
Sanofi-Aventis handed over Actonel marketing rights in the US to its collaborator on the drug, Warner Chilcott. Under the new agreement, Warner Chilcott will take full operational control over promotion, marketing and R&D decisions in the US and Puerto Rico. As part of the deal, Warner Chilcott will offer "a number of sales reps currently promoting Actonel for Sanofi-Aventis" jobs on the Warner Chilcott sales force, according to a company statement.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.